FTC cracking down on junk patents in drugs like Ozempic
The disputed patents include a junk patent for Ozempic, among other drugs for COPD, diabetes, weight loss, and asthma.
Source: washingtonexaminer.com
Stay updated with breaking news from Robert Califf. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The disputed patents include a junk patent for Ozempic, among other drugs for COPD, diabetes, weight loss, and asthma.
Observers expect the move will face legal challenges, prompt intervention from Congress.
Observers expect the move will face legal challenges, prompt intervention from Congress.
Observers expect the move will face legal challenges, prompt intervention from Congress.
Observers expect the move will face legal challenges, prompt intervention from Congress.